Matches in Nanopublications for { ?s ?p "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP245722.RAWigcxJupnwuM_zJhD1qz-hm6iQ4PDWhi0feqUvMHV1Y130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245722.RAWigcxJupnwuM_zJhD1qz-hm6iQ4PDWhi0feqUvMHV1Y130_provenance.
- NP760117.RAOIFM77OBAg6eaY2rFzj8zmOdqmn46KBqUX3fM_g94S0130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760117.RAOIFM77OBAg6eaY2rFzj8zmOdqmn46KBqUX3fM_g94S0130_provenance.
- NP245723.RAC6Ajhh6UaP6Hc6wOAChiLww1i8Zxvcz5ypSG5UmdpoY130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245723.RAC6Ajhh6UaP6Hc6wOAChiLww1i8Zxvcz5ypSG5UmdpoY130_provenance.
- NP433489.RAEax7YccpcIlxJgjsgEhS0ReT3gc4ddbczvGMULYUYOA130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433489.RAEax7YccpcIlxJgjsgEhS0ReT3gc4ddbczvGMULYUYOA130_provenance.
- NP433545.RAIxburRDwYRSCuI4sx4RP5SuRj5Re0xEkjcNVu_xzkHc130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433545.RAIxburRDwYRSCuI4sx4RP5SuRj5Re0xEkjcNVu_xzkHc130_provenance.
- NP245721.RAFo0zd1jluxSYbO4iiunaVLqA--Z3bl-0xV-nGWkzuDM130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245721.RAFo0zd1jluxSYbO4iiunaVLqA--Z3bl-0xV-nGWkzuDM130_provenance.
- NP245724.RAJ-1dYr1XQu-YkfteYMHkWn21EB7aZEWIMBv-SZqhOCU130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245724.RAJ-1dYr1XQu-YkfteYMHkWn21EB7aZEWIMBv-SZqhOCU130_provenance.
- NP245726.RAOHpv_JQnVbATiYuzmRxat_Vpg_xC5HXndzHDdyBhRms130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245726.RAOHpv_JQnVbATiYuzmRxat_Vpg_xC5HXndzHDdyBhRms130_provenance.
- NP245725.RA0L10Jva6kEC8-2EDg-o0b7wE4t0WhapAR5WdOvcfZpU130_assertion description "[Grb2 inhibition led to MAP kinase inactivation in EGFR, but not in ErbB2, breast cancer cells, suggesting that different pathways might be used by EGFR and ErbB2 to regulate breast cancer growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245725.RA0L10Jva6kEC8-2EDg-o0b7wE4t0WhapAR5WdOvcfZpU130_provenance.